Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1472 results

TAVI: how to deal with aortic regurgitation

16 May 2024 – From EuroPCR 2024

This session will explore various cases of TAVI for the management of aortic regurgitation, including patients with pure aortic regurgitation, large annuli, low coronary height, and left ventricular assist devices. Discussions will focus on the transcatheter approach, device selection, and techniques to address these challenging scenarios.

TAVI: how to deal with aortic regurgitation

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration

16 May 2024 – From EuroPCR 2024

In this session, learn how to advance heart team collaboration through optimized TAVI pre-work-up and refined severe aortic stenosis patient selection, ensuring accurate intervention indications. Gain hands-on insights for effective post-TAVI strategies, explore procedural and valve refinements that simplify post-TAVI PCI, and stay informed on the...

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration

Align for the future with case-based discussions on next generation balloon expandable transcatheter heart valve technology

16 May 2024 – From EuroPCR 2024

Join this EuroPCR 2024 session to delve into the cutting-edge innovations and techniques shaping transcatheter heart valve interventions. Witness firsthand the versatility of the Myval Octacor THV platform, navigating through challenging scenarios with ease, explore the significance of lifetime patient management in TAVI, unveiling the novel...

Align for the future with case-based discussions on next generation balloon expandable transcatheter heart valve technology

REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024

15 May 2024

The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.

REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024

Valve-in-valve: utility of splitting devices

15 May 2024 – From EuroPCR 2024

This session focuses on the use of specialized splitting devices for transcatheter aortic valve-in-valve procedures. It features a case series demonstrating the application of a dedicated splitting device in failed TAVI valves, as well as the use of the BASILICA technique for transcatheter aortic valve replacement....

Valve-in-valve: utility of splitting devices

These EuroIntervention papers changed my practice!

15 May 2024 – From EuroPCR 2024

These EuroIntervention papers changed my practice!

Challenging situations to access the aortic valve - Part 1

15 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions that showcase challenging situations in accessing the aortic valve, including cases with severe peripheral arterial disease, tortuous aortic anatomy, and complex comorbidities. The session provides an opportunity to learn from the experiences of experts in navigating these complex scenarios...

Challenging situations to access the aortic valve - Part 1

Valve-in-valve

15 May 2024 – From EuroPCR 2024

Valve-in-valve

TAVI for a lifetime

15 May 2024 – From EuroPCR 2024

This session explores long-term aspects of TAVI, focusing on patient life expectancy and valve durability. It provides guidance on optimizing initial TAVI procedures for patients with extended life spans and offers insights into planning and performing redo TAVI. Topics include assessing life expectancy, evaluating TAVI valve...

TAVI for a lifetime

TAVI hotline: long-term registry data

15 May 2024 – From EuroPCR 2024

This session presents and discusses long-term registry data on various aspects of transcatheter aortic valve implantation (TAVI). It covers topics such as the surgical versus transcatheter approach in combined coronary and aortic valve disease, long-term outcomes of TAVI versus surgical aortic valve replacement, and registry data...

TAVI hotline: long-term registry data

Vascular access complications following TAVI

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the management of vascular access complications following TAVI procedures. It will cover topics such as the management of a snapped single ProGlide, the use of distal femoral access to manage TAVI vascular complications, and the...

Vascular access complications following TAVI

Challenging situations to access the aortic valve - Part 2

15 May 2024 – From EuroPCR 2024

This session features a series of selected EuroPCR 2024 Clinical Case submissions, showcasing various challenging scenarios encountered during transcatheter aortic valve interventions. Experts will present and discuss cases involving transbrachial TAVI, TAVI on a porcelain aorta, transcaval access, and other complex access approaches, providing valuable insights...

Challenging situations to access the aortic valve - Part 2

TAVI in cardiogenic shock

15 May 2024 – From EuroPCR 2024

TAVI in cardiogenic shock

Complex scenarios beyond complex interventions, time to take multiple factors into account

15 May 2024 – From EuroPCR 2024

Complex scenarios beyond complex interventions, time to take multiple factors into account

LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

15 May 2024 – From EuroPCR 2024

This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...

LANDMARK RCT - Early

Contemporary TAVI: the VISION of lifetime management

15 May 2024 – From EuroPCR 2024

In this session, discover how pre-procedural assessment is used to optimize procedural outcomes, ensuring the best possible results for patients undergoing TAVI, learn the intricacies of selecting the most suitable valve for each individual patient, considering their unique anatomical and clinical factors, and engage in discussions...

Contemporary TAVI: the VISION of lifetime management

How does the female heart respond to severe aortic stenosis and aortic intervention?

15 May 2024 – From EuroPCR 2024

In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...

How does the female heart

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

15 May 2024 – From EuroPCR 2024

Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

TAVI: new devices, original solutions for procedural complications

15 May 2024 – From EuroPCR 2024

TAVI: new devices, original solutions for procedural complications

Innovation and strategies in TAVI: design, data and directions for clinical practice

15 May 2024 – From EuroPCR 2024

Watch this session to explore considerations for TAVI implantation in small annuli, gain insights into future lifetime management, learn about the benefits of FX technology and clinical evidence beyond small annuli, and witness a live case procedure showcasing the innovation of FX plus. This session is...

Innovation and strategies in TAVI: design, data and directions for clinical practice